4//SEC Filing
Hesslein Robert W. 4
Accession 0001104659-22-025672
CIK 0001640266other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:37 PM ET
Size
5.7 KB
Accession
0001104659-22-025672
Insider Transaction Report
Form 4
Hesslein Robert W.
Senior VP & General Counsel
Transactions
- Sale
Common Stock
2022-02-17$3.55/sh−4,100$14,555→ 122,704 total
Footnotes (2)
- [F1]Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 16, 2022. The reporting person structured the durable automatic sales instructions to constitute a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.49 to $3.67, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001585018
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:37 PM ET
- Size
- 5.7 KB